{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T21:57:20Z","timestamp":1775771840533,"version":"3.50.1"},"reference-count":54,"publisher":"The Endocrine Society","issue":"12","license":[{"start":{"date-parts":[[2020,8,22]],"date-time":"2020-08-22T00:00:00Z","timestamp":1598054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Nephrolithiasis (NL) and primary hyperparathyroidism (HPTH) are metabolic complications of Paget disease of bone (PDB), but recent data regarding their prevalence in PDB patients are lacking.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Study 1: To compare the prevalence of primary HPTH and NL in 708 patients with PDB and in 1803 controls. Study 2: To evaluate the prevalence of NL-metabolic risk factors in 97 patients with PDB and NL, 219 PDB patients without NL, 364 NL patients without PDB, and 219 controls, all of them without HPTH.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>Cross-sectional multicentric study.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Setting<\/jats:title>\n                  <jats:p>Italian referral centers for metabolic bone disorders.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Participants<\/jats:title>\n                  <jats:p>Patients with PDB from the Associazione Italiana malati di osteodistrofia di Paget registry. Participants in the Olivetti Heart and the Siena Osteoporosis studies.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main Outcome Measures<\/jats:title>\n                  <jats:p>HPTH; NL; NL-metabolic risk factors.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Patients with PDB showed higher prevalence of primary HPTH and NL compared with controls (P &amp;lt; 0.01). The NL recurrence occurs more frequently in patients with polyostotic PDB. About one-half of patients with PDB but without NL showed 1 or more NL-related metabolic risk factors. The hyperoxaluria (HyperOx) prevalence was higher in patients with PDB and NL compared with patients with NL but without PDB and in patients with PDB without NL compared with controls (P = 0.01). Patients with PDB and HyperOx showed a longer lapse of time from the last aminobisphosphonate treatment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>NL and HPTH are frequent metabolic complication of PDB. The NL occurrence should be evaluated in patients with PDB, particularly in those with polyostotic disease and\/or after aminobisphosphonate treatment to apply an adequate prevention strategy.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgaa576","type":"journal-article","created":{"date-parts":[[2020,8,22]],"date-time":"2020-08-22T18:16:56Z","timestamp":1598120216000},"page":"e4430-e4438","source":"Crossref","is-referenced-by-count":10,"title":["Increased Prevalence of Nephrolithiasis and Hyperoxaluria in Paget Disease of Bone"],"prefix":"10.1210","volume":"105","author":[{"given":"Domenico","family":"Rendina","sequence":"first","affiliation":[{"name":"Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1313-5599","authenticated-orcid":false,"given":"Gianpaolo","family":"De Filippo","sequence":"additional","affiliation":[{"name":"Assistance Publique-H\u00f4pitaux de Paris, H\u00f4pital Robert-Debr\u00e9, Service d\u2019Endocrinologie et Diab\u00e9tologie P\u00e9diatrique, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Merlotti","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Di Stefano","sequence":"additional","affiliation":[{"name":"Department of Medical Science, Gerontology and Bone Metabolic Diseases, University of Torino, Torino, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Mingiano","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso","family":"Giaquinto","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Evangelista","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2945-0243","authenticated-orcid":false,"given":"Mario","family":"Bo","sequence":"additional","affiliation":[{"name":"Department of Medical Science, Gerontology and Bone Metabolic Diseases, University of Torino, Torino, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Arpino","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaella","family":"Faraonio","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pasquale","family":"Strazzullo","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6833-4232","authenticated-orcid":false,"given":"Luigi","family":"Gennari","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2020,8,22]]},"reference":[{"issue":"5","key":"2021122106251853000_CIT0001","doi-asserted-by":"crossref","first-page":"299","DOI":"10.4111\/icu.2017.58.5.299","article-title":"Epidemiology and economics of nephrolithiasis","volume":"58","author":"Ziemba","year":"2017","journal-title":"Investig Clin Urol."},{"issue":"10","key":"2021122106251853000_CIT0002","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1172\/JCI26662","article-title":"Kidney stone disease","volume":"115","author":"Coe","year":"2005","journal-title":"J Clin Invest."},{"issue":"10116","key":"2021122106251853000_CIT0003","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0140-6736(17)31430-7","article-title":"Hyperparathyroidism","volume":"391","author":"Bilezikian","year":"2018","journal-title":"Lancet."},{"issue":"11","key":"2021122106251853000_CIT0004","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1007\/s00198-016-3658-8","article-title":"Nephrolithiasis, bone mineral density, osteoporosis, and fractures: a systematic review and comparative meta-analysis","volume":"27","author":"Lucato","year":"2016","journal-title":"Osteoporos Int."},{"issue":"4","key":"2021122106251853000_CIT0005","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/0049-0172(94)90037-X","article-title":"Epidemiological aspects of Paget\u2019s disease: family history and relationship to other medical conditions","volume":"23","author":"Siris","year":"1994","journal-title":"Semin Arthritis Rheum."},{"issue":"5","key":"2021122106251853000_CIT0006","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00223-019-00522-3","article-title":"Paget\u2019s disease of bone","volume":"104","author":"Gennari","year":"2019","journal-title":"Calcif Tissue Int."},{"issue":"6","key":"2021122106251853000_CIT0007","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00068-008-8208-4","article-title":"The second most common bone disease: a review on Paget\u2019s disease of bone","volume":"34","author":"Seitz","year":"2008","journal-title":"Eur J Trauma Emerg Surg."},{"issue":"2","key":"2021122106251853000_CIT0008","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.bone.2013.04.024","article-title":"Epidemiology of Paget\u2019s disease of bone: a systematic review and meta-analysis of secular changes","volume":"55","author":"Corral-Gudino","year":"2013","journal-title":"Bone."},{"issue":"3","key":"2021122106251853000_CIT0009","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1359\/jbmr.2002.17.3.465","article-title":"Incidence and natural history of Paget\u2019s disease of bone in England and Wales","volume":"17","author":"van Staa","year":"2002","journal-title":"J Bone Miner Res."},{"issue":"12","key":"2021122106251853000_CIT0010","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1359\/jbmr.060822","article-title":"Evidence for increased clinical severity of familial and sporadic Paget\u2019s disease of bone in Campania, southern Italy","volume":"21","author":"Rendina","year":"2006","journal-title":"J Bone Miner Res."},{"issue":"4","key":"2021122106251853000_CIT0011","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/jbmr.3657","article-title":"Diagnosis and management of Paget\u2019s disease of bone in adults: a clinical guideline","volume":"34","author":"Ralston","year":"2019","journal-title":"J Bone Miner Res."},{"issue":"7","key":"2021122106251853000_CIT0012","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMcp1204713","article-title":"Clinical practice. Paget\u2019s disease of bone","volume":"368","author":"Ralston","year":"2013","journal-title":"N Engl J Med."},{"key":"2021122106251853000_CIT0013","doi-asserted-by":"crossref","first-page":"P69","DOI":"10.1359\/jbmr.06s213","article-title":"What is the relationship between Paget\u2019s disease of bone and hyperparathyroidism?","volume":"21","author":"Brandi","year":"2006","journal-title":"J Bone Miner Res."},{"issue":"6","key":"2021122106251853000_CIT0014","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s002239900728","article-title":"Thirty cases of concurrent Paget\u2019s disease and primary hyperparathyroidism: sex distribution, histomorphometry, and prediction of the skeletal response to parathyroidectomy","volume":"65","author":"Gutteridge","year":"1999","journal-title":"Calcif Tissue Int."},{"key":"2021122106251853000_CIT0015"},{"key":"2021122106251853000_CIT0016"},{"issue":"1","key":"2021122106251853000_CIT0017","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1530\/EJE-10-0043","article-title":"FSHR gene polymorphisms influence bone mineral density and bone turnover in postmenopausal women","volume":"163","author":"Rendina","year":"2010","journal-title":"Eur J Endocrinol."},{"issue":"4","key":"2021122106251853000_CIT0018","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s00223-019-00578-1","article-title":"Vitamin D status in Paget disease of bone and efficacy-safety profile of cholecalciferol treatment in pagetic patients with hypovitaminosis D","volume":"105","author":"Rendina","year":"2019","journal-title":"Calcif Tissue Int."},{"issue":"6","key":"2021122106251853000_CIT0019","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/jbmr.31","article-title":"SQSTM1 gene analysis and gene-environment interaction in Paget\u2019s disease of bone","volume":"25","author":"Gennari","year":"2010","journal-title":"J Bone Miner Res."},{"issue":"3","key":"2021122106251853000_CIT0020","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1093\/ndt\/gfn548","article-title":"Association between metabolic syndrome and nephrolithiasis in an inpatient population in southern Italy: role of gender, hypertension and abdominal obesity","volume":"24","author":"Rendina","year":"2009","journal-title":"Nephrol Dial Transplant."},{"issue":"11","key":"2021122106251853000_CIT0021","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1093\/ndt\/16.11.2232","article-title":"Past history of nephrolithiasis and incidence of hypertension in men: a reappraisal based on the results of the Olivetti Prospective Heart Study","volume":"16","author":"Strazzullo","year":"2001","journal-title":"Nephrol Dial Transplant."},{"issue":"6","key":"2021122106251853000_CIT0022","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/j.1365-2265.2011.04285.x","article-title":"Impact of vitamin D-related serum PTH reference values on the diagnosis of mild primary hyperparathyroidism, using bivariate calcium\/PTH reference regions","volume":"76","author":"Fill\u00e9e","year":"2012","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"9","key":"2021122106251853000_CIT0023","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med."},{"issue":"6","key":"2021122106251853000_CIT0024","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s40620-016-0329-y","article-title":"Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement","volume":"29","author":"Gambaro","year":"2016","journal-title":"J Nephrol."},{"key":"2021122106251853000_CIT0025"},{"issue":"2","key":"2021122106251853000_CIT0026","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1046\/j.1365-2796.2003.01086.x","article-title":"Association between vitamin D receptor gene polymorphisms and tubular citrate handling in calcium nephrolithiasis","volume":"253","author":"Mossetti","year":"2003","journal-title":"J Intern Med."},{"issue":"9821","key":"2021122106251853000_CIT0027","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/S0140-6736(11)60276-6","article-title":"Subclinical thyroid disease","volume":"379","author":"Cooper","year":"2012","journal-title":"Lancet."},{"key":"2021122106251853000_CIT0028"},{"key":"2021122106251853000_CIT0029","volume-title":"Pathophysiology and Treatment of Paget\u2019s Disease of Bone","author":"Kanis","year":"1998","edition":"2"},{"issue":"12","key":"2021122106251853000_CIT0030","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1210\/js.2019-00316","article-title":"Clinical presentation of primary hyperparathyroidism in older adults","volume":"3","author":"Castellano","year":"2019","journal-title":"J Endocr Soc."},{"key":"2021122106251853000_CIT0031","first-page":"w13979","article-title":"Bisphosphonate induced hypocalcaemia - report of six cases and review of the literature","volume":"144","author":"Kreutle","year":"2014","journal-title":"Swiss Med Wkly."},{"issue":"3","key":"2021122106251853000_CIT0032","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2174\/1574886311666160426141647","article-title":"Zoledronate induced hypocalcemia and hypophosphatemia in osteoporosis: a cause of concern","volume":"11","author":"Kaur","year":"2016","journal-title":"Curr Drug Saf."},{"issue":"3","key":"2021122106251853000_CIT0033","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s11739-019-02048-w","article-title":"Hypocalcemia and hypophosphatemia after treatment with zoledronic acid in a patient with AL amyloidosis","volume":"14","author":"Tufano","year":"2019","journal-title":"Intern Emerg Med."},{"issue":"1","key":"2021122106251853000_CIT0034","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00240-016-0952-z","article-title":"The role of intestinal oxalate transport in hyperoxaluria and the formation of kidney stones in animals and man","volume":"45","author":"Whittamore","year":"2017","journal-title":"Urolithiasis."},{"issue":"2","key":"2021122106251853000_CIT0035","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJMoa010369","article-title":"Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria","volume":"346","author":"Borghi","year":"2002","journal-title":"N Engl J Med."},{"issue":"2","key":"2021122106251853000_CIT0036","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4081\/aiua.2015.2.105","article-title":"Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group","volume":"87","author":"Prezioso","year":"2015","journal-title":"Arch Ital Urol Androl."},{"key":"2021122106251853000_CIT0037","first-page":"CD006022","article-title":"Dietary interventions for preventing complications in idiopathic hypercalciuria","volume":"2","author":"Escribano","year":"2014","journal-title":"Cochrane Database Syst Rev."},{"issue":"9","key":"2021122106251853000_CIT0038","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/ejcn.2016.79","article-title":"Factors associated with patient recall of individualized dietary recommendations for kidney stone prevention","volume":"70","author":"Penniston","year":"2016","journal-title":"Eur J Clin Nutr."},{"issue":"4","key":"2021122106251853000_CIT0039","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00240-016-0916-3","article-title":"Renal stone clinic survey: calcium stone formers\u2019 self-declared understanding of and adherence to physician\u2019s recommendations","volume":"45","author":"Hess","year":"2017","journal-title":"Urolithiasis."},{"issue":"8","key":"2021122106251853000_CIT0040","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1007\/s00198-015-3128-8","article-title":"Self-reported calcium use in a cohort of postmenopausal women receiving osteoporosis therapy: results from POSSIBLE US\u2122","volume":"26","author":"Barrett-Connor","year":"2015","journal-title":"Osteoporos Int."},{"issue":"3","key":"2021122106251853000_CIT0041","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.joms.2017.08.019","article-title":"In vitro investigation of the antimicrobial effect of three bisphosphonates against different bacterial strains","volume":"76","author":"Ermer","year":"2018","journal-title":"J Oral Maxillofac Surg."},{"issue":"2","key":"2021122106251853000_CIT0042","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3390\/nu12020548","article-title":"Calcium oxalate nephrolithiasis and gut microbiota: not just a gut-kidney axis. A nutritional perspective","volume":"12","author":"Ticinesi","year":"2020","journal-title":"Nutrients."},{"key":"2021122106251853000_CIT0043"},{"issue":"3","key":"2021122106251853000_CIT0044","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2265.1991.tb00294.x","article-title":"Intravenous aminobisphosphonate in Paget\u2019s disease: clinical, biochemical, histomorphometric and radiological responses","volume":"34","author":"Fenton","year":"1991","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"8","key":"2021122106251853000_CIT0045","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/21678707.2018.1500691","article-title":"Paget\u2019s disease of bone: an update on epidemiology, pathogenesis and pharmacotherapy","volume":"6","author":"Gennari","year":"2018","journal-title":"Expert Opin Orphan Drugs."},{"issue":"5311","key":"2021122106251853000_CIT0046","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1126\/science.276.5311.404","article-title":"Positional cloning of the gene for multiple endocrine neoplasia-type 1","volume":"276","author":"Chandrasekharappa","year":"1997","journal-title":"Science."},{"issue":"36","key":"2021122106251853000_CIT0047","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.1038\/sj.onc.1204529","article-title":"The tumor suppressor protein menin interacts with NF-kappaB proteins and inhibits NF-kappaB-mediated transactivation","volume":"20","author":"Heppner","year":"2001","journal-title":"Oncogene."},{"issue":"7","key":"2021122106251853000_CIT0048","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.bbadis.2014.03.006","article-title":"Paget disease of bone-associated UBA domain mutations of SQSTM1 exert distinct effects on protein structure and function","volume":"1842","author":"Goode","year":"2014","journal-title":"Biochim Biophys Acta."},{"key":"2021122106251853000_CIT0049","doi-asserted-by":"crossref","DOI":"10.1007\/978-94-011-4663-0_4","article-title":"Carryover effects in clinical research.","volume-title":"Human Experimentation","author":"Cleophas","year":"1999"},{"issue":"1","key":"2021122106251853000_CIT0050","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2265.1973.tb03480.x","article-title":"Parathyroid function in patients with Paget\u2019s disease treated with salmon calcitonin","volume":"2","author":"Burckhardt","year":"1973","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"3","key":"2021122106251853000_CIT0051","first-page":"329","article-title":"Plasma calcitonin in Paget\u2019s disease of bone","volume":"52","author":"Kanis","year":"1977","journal-title":"Clin Sci Mol Med."},{"key":"2021122106251853000_CIT0052","first-page":"N18","article-title":"Epidemiology of primary hyperparathyroidism in Europe","volume":"17","author":"Adami","year":"2002","journal-title":"J Bone Miner Res."},{"issue":"3","key":"2021122106251853000_CIT0053","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1210\/jc.2012-4022","article-title":"Incidence and prevalence of primary hyperparathyroidism in a racially mixed population","volume":"98","author":"Yeh","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2021122106251853000_CIT0054","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00240-016-0938-x","article-title":"Nephrolithiasis as a risk factor of chronic kidney disease: a meta-analysis of cohort studies with 4,770,691 participants","volume":"45","author":"Zhe","year":"2017","journal-title":"Urolithiasis."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaa576\/33674825\/dgaa576.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/105\/12\/e4430\/41829272\/dgaa576.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/105\/12\/e4430\/41829272\/dgaa576.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T06:26:25Z","timestamp":1640067985000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/105\/12\/e4430\/5896000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,22]]},"references-count":54,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,8,22]]},"published-print":{"date-parts":[[2020,12,1]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaa576","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,12]]},"published":{"date-parts":[[2020,8,22]]}}}